​

SpringWorks Therapeutics Ownership | Who Owns SpringWorks Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

SpringWorks Therapeutics Ownership Summary

SpringWorks Therapeutics is owned by 108.19% institutional investors, 1.92% insiders. Fmr is the largest institutional shareholder, holding 15.06% of SWTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.71% of its assets in SpringWorks Therapeutics shares.

SWTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSpringWorks Therapeutics108.19%1.92%-10.11%
SectorHealthcare Stocks 87.31%8.86%3.83%
IndustryBiotech Stocks 108.49%8.78%-17.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.11M15.06%$418.60M
Vanguard group6.54M8.87%$246.53M
Blackrock5.62M7.62%$211.68M
Deep track capital, lp3.70M5.02%$139.38M
Price t rowe associates inc /md/3.60M4.88%$135.70M
Boxer capital3.42M4.64%$128.89M
State street3.09M4.18%$116.28M
Maverick capital2.60M3.53%$97.96M
Marshall wace, llp2.33M3.16%$87.89M
Lord, abbett2.07M2.81%$78.13M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management233.20K8.20%$8.78M
Finepoint capital lp638.35K6.83%$24.05M
Boxer capital3.42M6.79%$128.89M
M28 capital management lp110.40K5.39%$4.16M
Deep track capital, lp3.70M4.16%$139.38M
Bridger management144.53K2.80%$5.44M
Maverick capital2.60M1.86%$97.96M
Perceptive advisors1.65M1.48%$62.27M
Duquesne family office1.02M1.32%$38.48M
Orbimed advisors1.71M1.28%$64.32M

Top Buyers

HolderShares% AssetsChange
Duquesne family office1.02M1.32%1.02M
Maverick capital2.60M1.86%691.89K
Polar capital1.00M0.22%650.00K
Gw&k investment management683.54K0.24%573.94K
Woodline partners lp1.36M0.49%495.18K

Top Sellers

HolderShares% AssetsChange
Point72 asset management---1.49M
Deerfield management company, l.p. (series c)---1.28M
Marshall wace, llp2.33M0.12%-633.50K
Perceptive advisors1.65M1.48%-609.50K
Price t rowe associates inc /md/3.60M0.02%-508.23K

New Positions

HolderShares% AssetsChangeValue
Duquesne family office1.02M1.32%1.02M$38.48M
Eagle asset management327.85K0.07%327.85K$12.63M
Norges bank280.34K0.00%280.34K$10.56M
Rock springs capital management lp199.85K0.23%199.85K$7.53M
Segall bryant & hamill140.44K0.09%140.44K$5.29M

Sold Out

HolderChange
Riggs asset managment-7.00
Allworth financial lp-12.00
Parallax volatility advisers-16.00
Geneos wealth management-20.00
Quadrant capital group-23.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242276.57%80,349,0324.19%1080.99%1292.38%5911.32%
Jun 30, 2024213-6.99%77,114,142-0.98%1040.94%126-11.89%53-3.64%
Mar 31, 202422923.12%77,880,4403.37%1051.00%1437.52%5566.67%
Dec 31, 202318624.83%75,339,87710.09%1020.86%13384.72%33-26.67%
Sep 30, 20231492.76%68,434,758-1.68%1090.88%72-13.25%4525.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S4.99M6.71%24.48K
Fidelity Growth Compy Commingled Pl O4.81M6.48%13.68K
Fidelity Growth Company Fund3.61M4.85%-8.80K
Vanguard Total Stock Mkt Idx Inv2.07M2.78%-10.48K
iShares Russell 2000 ETF1.84M2.48%-7.08K
Vanguard Small Cap Index1.68M2.26%9.90K
Polar Capital Biotech S Inc1.50M2.02%-
US Small-Cap Growth II Equity Comp1.48M1.99%-5.25K
T. Rowe Price New Horizons1.47M1.98%-957.00
SPDR® S&P Biotech ETF1.40M1.88%-16.37K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 03, 2024Edris Badreddin Chief Operating OfficerSell$499.94K
Dec 03, 2024Edris Badreddin Chief Operating OfficerSell$339.39K
Dec 02, 2024Islam Saqib Chief Executive OfficerSell$1.86M
Dec 02, 2024Islam Saqib Chief Executive OfficerSell$166.94K
Sep 03, 2024Islam Saqib Chief Executive OfficerSell$281.55K

Insider Transactions Trends

DateBuySell
2024 Q4-4
2024 Q3-6
2024 Q2-12
2024 Q1-10
2023 Q4--

SWTX Ownership FAQ

Who Owns SpringWorks Therapeutics?

SpringWorks Therapeutics shareholders are primarily institutional investors at 108.19%, followed by 1.92% insiders and -10.11% retail investors. The average institutional ownership in SpringWorks Therapeutics's industry, Biotech Stocks , is 108.49%, which SpringWorks Therapeutics falls below.

Who owns the most shares of SpringWorks Therapeutics?

SpringWorks Therapeutics’s largest shareholders are Fmr (11.11M shares, 15.06%), Vanguard group (6.54M shares, 8.87%), and Blackrock (5.62M shares, 7.62%). Together, they hold 31.55% of SpringWorks Therapeutics’s total shares outstanding.

Does Blackrock own SpringWorks Therapeutics?

Yes, BlackRock owns 7.62% of SpringWorks Therapeutics, totaling 5.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 211.68M$. In the last quarter, BlackRock increased its holdings by 180.4K shares, a 3.32% change.

Who is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested?

Oracle investment management is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.20% of its assets in 233.2K SpringWorks Therapeutics shares, valued at 8.78M$.

Who is the top mutual fund holder of SpringWorks Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of SpringWorks Therapeutics shares, with 6.71% of its total shares outstanding invested in 4.99M SpringWorks Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools